Determination of the effect of formulation on the bioavailability of topical corticoids by non-contact reflectometry
Le Gall, F.; Levèque, J.L.; Poelman, M.C.
Pharmaceutica Acta Helvetiae 60(4): 125-128
1985
ISSN/ISBN: 0031-6865 PMID: 4011625 Document Number: 250404
Document emailed within 1 workday
Related Documents
Scheidel, B.; Blume, H.; Walter, K.; von Nieciecki, A.; Babej-Dölle, R.M. 1993: Biological availability of gastric juice-resistant coated diclofenac preparations. 1. Bioavailability study following a single administration of a multiple-unit formulation in comparison with a single-unit formulation Arzneimittel-Forschung 43(11): 1211-1215Koch, E.; Loebich, F.; Frosch, P.J. 1983: Skin tolerance of topical corticoids as dependent upon the pH value of the emulsions Dermatosen in Beruf und Umwelt. Occupation and Environment 31(4): 122-126
2003: Calcineurin inhibitors in treatment of atopic dermatitis. Topical corticoids now only in severe outbreaks? MMWFortschrittederMedizin 145(29-30): 62
Maier-Lenz, H.; Ringwelski, L.; Windorfer, A. 1980: Pharmacokinetics and relative bioavailability of a nitroglycerin ointment formulation Arzneimittel-Forschung 30(2): 320-324
Macía, M.A.; Frias, J.; Carcas, A.J.; Guerra, P.; Valiente, R.; Lucero, M.L. 1995: Comparative bioavailability of a dispersible formulation of diclofenac and finding of double plasma peaks International Journal of Clinical Pharmacology and Therapeutics 33(6): 333-339
Wang, Y.J.; Leesman, G.D.; Lipstein, M.E.; Basch, H.I.; Monkhouse, D.C. 1984: Optimization of autoclave cycles and selection of formulation for parenteral products, Part III: Effect of formulation variables on sporicidal kinetics Journal of parenteral science and technology: a publication of the Parenteral Drug Association 38(2): 78-82
Degen, J.; Wölke, E.; Seiberling, M.; Thomann, P.; Völter-Erhardt, H. 1997: Comparison of the relative bioavailability and pharmacokinetics of estrone after oral administration of esterified estrogens in a tablet formulation and an aqueous suspension Arzneimittel-Forschung 47(2): 208-212
Ayanoglu, G.; Witte, P.U.; Badian, M. 1983: Bioavailability and pharmacodynamics of a sustained-release glibenclamide product (Deroctyl) in comparison to a standard tablet formulation (Euglucon, Daonil) International Journal of Clinical Pharmacology Therapy and Toxicology 21(9): 479-482
Kim, S.Tae.; Jang, D-Jin.; Kim, J.Hyo.; Park, J.Yeon.; Lim, J.Soo.; Lee, S.Yeon.; Lee, K-Mi.; Lim, S-Jeong.; Kim, C-Kook. 2009: Topical administration of cyclosporin A in a solid lipid nanoparticle formulation Die Pharmazie 64(8): 510-514
Hirst, C. 1980: Topical steroid preparations. the relationship between the clinical use and the formulation of the product base Australian Family Physician 9(11): 816-819
Lundell, E. 1975: A double blind trial of a new topical steroid formulation containing desoximetasone against fluocinolonacetonid cream Zeitschrift für Hautkrankheiten Suppl 2: 17-19
Harper, J.C. 2010: Benzoyl peroxide development, pharmacology, formulation and clinical uses in topical fixed-combinations Journal of Drugs in Dermatology: Jdd 9(5): 482-487
Gul, R.; Jan, S.U.; Ahmed, M.; Akhtar, M.; Qureshi, M.M. 2019: Formulation, characterization and in vivo evaluation of Hedera helix L., topical dosage forms Pakistan Journal of Pharmaceutical Sciences 32(6): 2605-2610
Seth, B.L. 1992: Comparative pharmacokinetics and bioavailability study of percutaneous absorption of diclofenac from two topical formulations containing drug as a solution gel or as an emulsion gel Arzneimittel-Forschung 42(2): 120-122
Spencer, J.M.; Morgan, M.B.; Trapp, K.M.; Moon, S.D. 2013: Topical formulation engendered alteration in p53 and cyclobutane pyrimidine dimer expression in chronic photodamaged patients Journal of Drugs in Dermatology: Jdd 12(3): 336-340
Maqsood, I.; Masood, M.I.; Nawaz, H.A.; Shahzadi, I.; Arslan, N. 2019: Formulation, characterization and in vitro evaluation of antifungal activity of Nystatin micro emulsion for topical application Pakistan Journal of Pharmaceutical Sciences 32(4): 1671-1677
Fedler, R.; Pilz, B.; Frosch, P.J. 1993: Contact allergy to topical glucocorticoids Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 44(2): 91-95
Woodford, R.; Barry, B.W. 1974: Bioavailability and activity of betamethasone 17-benzoate in gel and cream formulations: comparison with proprietary topical corticosteroid preparations in the vasoconstrictor assay Current Therapeutic Research 16(4): 338-345
Szarmach, H.; Wroński, A.; Podziewski, J. 1982: Problems of contact allergy to topical drugs Przeglad Dermatologiczny 69(4): 239-244
Holzer, A.M.; Kaplan, L.L.; Levis, W.R. 2006: Haptens as drugs: contact allergens are powerful topical immunomodulators Journal of Drugs in Dermatology: Jdd 5(5): 410-416